Objective: The phytohormone abscisic acid (ABA) as a signaling molecule exists in various types of organisms from early multicellular to animal cells and tissues. It has been demonstrated that ABA has an antinociceptive effect in rodents. The present study was designed to assess the possible role of PKA and phosphorylated ERK (p-ERK) on the antinociceptive effects of intrathecal (i.t.) ABA in male Wistar rats. Methods: The animals were cannulated intrathecally and divided into different experimental groups (n=6-7): Control (no surgery), vehicle (received ABA vehicle), ABA-treated groups (received ABA in doses of 10 or 20 µg/rat), ABA plus H.89 (PKA inhibitor)-treated group which received the inhibitor 15 min prior to the ABA injection. Tail-flick and hot-plate tests were used as acute nociceptive stimulators to assess ABA analgesic effects. p-ERK was evaluated in the dorsal portion of the spinal cord using immunoblotting. Results: Data showed that a microinjection of ABA (10 and 20 µg/rat, i.t.) significantly increased the nociceptive threshold in tail flick and hot plate tests. The application of PKA inhibitor (H.89, 100 nM/rat) significantly inhibited ABA-induced analgesic effects. Expression of p-ERK was significantly decreased in ABA-injected animals, which were not observed in the ABA+H.89-treated group. Conclusions: Overall, i.t. administration of ABA (10 µg/ rat) induced analgesia and p-ERK down-expression likely by involving the PKA-dependent mechanism.
Spinal protein kinase A and phosphorylated extracellular signal-regulated kinase signaling are involved in the antinociceptive effect of phytohormone abscisic acid in rats
A proteína quinase A da medula espinhal e a sinalização da quinase fosforilada regulada por sinal extracelular estão envolvidas no efeito antinociceptivo do ácido fito-hormônio abscísico em ratos Phytohormone abscisic acid (ABA) is naturally produced by plants and has a very important physiological activities like plants disease resistance and plant response to environmental stressors 1, 2 . Production and accumulation of ABA by animal tissues has been reported 3 . Surprisingly, it is endogenously produced by mammalian brain. However, neurobiological effects of this phytoterpenoid have not been fully clarified. ABA is involved in numerous biological activities, such as migration, the release of anti-inflammatory cytokines, glucose homeostasis, stem cell expansion and, also, the control of inflammatory and immune responses 4, 5 . Potential antiinflammatory effects of ABA have been reported in inflammatory bowel diseases, atherosclerosis and obesity-related inflammation [6] [7] [8] . Plant and animal studies showed that ABA recruits a very wide spectrum of signaling pathways, such as: peroxisome proliferator-activated receptors (PPARs), lanthioninesynthetase C-like protein 2 (LANCL2), and several protein kinase, including PKA, PKC and phosphatidylinositol 3-Kinase 9, 10 . Recently, Naderi et al. reported that central microinjection of ABA improves cognitive functions and exhibits antianxiety effects with PKC and PI3 kinase signaling pathways 11 . ABA-induced insulin releasing effect, as one of the important and remarkable effects of ABA, is performed with PKA signaling 12 . We have previously reported that the central administration of ABA elicits antinociceptive effects in rats 13 . However, its detail mechanism is not yet fully elucidated.
It is well known that the spinal cord has an important role in pain transmission, regulation and processing. Specially, dorsal horn parts and laminas, connectivity of the pain first order neurons at spinal cord segments levels with another modality, such as tactile, have crucial responsibilities in pain control and transmission 14 .
In addition, ERK (extracellular signal-regulated kinase) is a family member of mitogen activated protein kinases (MAPKs), which is affected by acute damaging stimulation. Damaging stimulation-induced activation of ERK in spinal neurons contributes to the induction and maintenance of nociceptive pain hypersensitivity 15, 16 . Considering that the possible mechanisms of ABA-induced anti-nociception in the spinal cord levels are not yet clarified, this study was designed to evaluate the role of PKA signaling and ERK activity in ABA analgesic effect.
METHODS

Animal
Male Wistar rats (230-270 gr) were obtained from the Shahid Bahonar University of Kerman Animal House. The rats were housed under standard conditions (22±2°C with a 12 h light/dark cycle); food and water were available ad libitum throughout the experiment. After intrathecal (i.t.) cannulating, the rats were transmitted to the animal room and housed separately. Before initiating behavioral experiments, the rats were handled daily, for 4 consecutive days, to adjust them for the manipulation and reduction of nonspecific stress responses. All experiments followed the guidelines on ethical standards for investigation of experimental pain in animals and were approved by the Animal Experimentation Ethics Committee of the Kerman Neuroscience Research Center (EC/KNRC/96).
Drug
(±)-Cis,trans-ABA and PKA inhibitor (H.89) were purchased from Sigma-Aldrich (USA). ABA was dissolved in dimethyl sulfoxide (DMSO), then diluted with artificial cerebrospinal fluid (aCSF). The ratio of aCSF to DMSO was 2:1 (v/v). PKA inhibitor was dissolved in distilled water. These drugs were given in the volume of 10 µl (i.t.).
Experimental designs
Rats were randomly divided into five experimental groups (n=6-7). Control group (Cont), which had no surgery and treatment; vehicle-treated group (Veh), which received ABA vehicle; ABA-treated groups, different doses of ABA (10 or 20 µg/rat) were intrathecally administrated. ABA plus H.89treated group (H.89+ABA) were treated with 100nM/rat H.89 15 min prior to ABA injection.
Intrathecal catheterization protocol
The technique of spinal catheterization was carried out on anesthetized rats using intraperitoneal injection of ketamine and xylazine (50 and 5 mg/kg, respectively). In this method, PE10 polyethylene tubing was inserted in each rat, according to a previously published method 17 . Following intrathecal cannulation, rats showed neuronal disturbances, which were discarded from behavioral experiments. All animals were killed after the behavioral tests and their dissected lumbar spinal cords were transferred to liquid nitrogen for molecular study.
Tail flick test
The radiant heat analgesiometer as an apparatus for measuring central analgesic activity of drugs was used. The base part of the tails of the rats were located on a radiant heat source and the reaction time (the latency to withdrawal of the tail) was verified. The average value of three measurements was considered and used in the analysis. The mean baseline latencies obtained by calculating predrug was recorded three times. The cut-off time was fixed at 15 s to avoid any damage to the tail. After assessing the baseline threshold, rats were injected with the drugs and the reaction time was determined at varying times after drug injection. Tail-withdrawal latencies were expressed by mean to the percentage of antinociception, according to the following formula: %Antinociception (%MPE)=(reaction time of test-basal reaction time)/(cut-off time-basal reaction time)*100.
Hot plate
The hot plate test was used to measure the effectiveness of analgesics. Rats were individually retained on a metal surface at a stable temperature (52±2°C) and baseline nociceptive behaviors were recorded. To prevent tissue damage, 30 s cut-off time was considered. After drug injection, nociceptive behaviors (licking, lifting, or jumping) were recorded as post-drug latency responses: 30, 45, 60, 90, 120, 180, and 230 min after the drug treatments. The following formula was used to calculate the maximum possible effect (MPE): %MPE=(latency after drug administration-baseline latency)/ (cut-off time-baseline latency)*100.
Western blot
Rat spinal cord tissues were lysed in RIPA buffer, comprising 10 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 Mm ethylenediaminetetraacetic acid, 0.1% sodium dodecyl sulfate 0.1% Nadeoxycholate, 1% NP-401% NP-40 and protease inhibitors (1 mM phenylmethylsulfonyl fluoride, 2.5 µg/mL of leupeptin, 10 µg/mL of aprotinin) and 1 mM sodium orthovanadate. The same volumes of protein from samples (40 µg) were separated using sodium dodecyl sulfate polyacrylamide gel electrophoresis and moved to a polyvinyl difluoride membrane. Blots were then blocked with 3% nonfat milk in 0.1% Tween-Tris-buffered saline for two hours at room temperature, followed by overnight (4°C) incubation with p-ERK primary antibody (1:1000) (Santa Cruz, USA). The primary antibody was detected with goat anti mouse horseradish peroxidaseconjugated secondary antibody (1:15,000) (Santa Cruz, USA) for 60 min, at room temperature. The antibody-antigen complexes were identified using the ECL system and exposed to Lumi-Film chemiluminescent detection film. Image J software was used to evaluate the intensity of the blotting bands. GAPDH (1:10,000) immunoblot was used as loading control.
The expression values were presented as tested proteins/ GAPDH ratio for each rat.
Statistical analysis
Statistical Package for the Social Sciences (SPSS), version 19, was used. The results are expressed as mean±S.E.M. Significant differences in %MPE (antinociception) between groups over the times of the study were examined using one or, in some cases, two-way analysis of variance (ANOVA) followed by the Tukey's test. Values <0.05 were considered statistically significant.
RESULTS
Tail flick test
ABA potentials to modulate thermal nociceptive threshold was assessed by tail flick apparatus. As shown in Figure 1A , the microinjection of ABA (10 and 20 µg/rat, i.t.) significantly increased tail flick nociceptive threshold when compared to the control group. ABA vehicle injection had no effects on the nociceptive threshold. Intrathecal microinjection of 10 µg ABA increased the mean of latency time 30 min after injection, which had a peak 45 min after injection and terminated at 120 min. In addition, 20 µg ABA induced antinociception, beginning 45 min after the injection (p<0.001), then decreased gradually until 120 min ( Figure 1A) . Besides that, to explore the involvement of PKA signaling on ABA anti-nociceptive effect, H.89 (100 nM), a PKA inhibitor, was administrated 15 min prior to ABA (10 µg/rat). Results showed that prior treatment of H.89 (100 nM) was able to inhibit ABA-induced analgesic effect during the time course of tail flick test ( Figure 1B) . Hot plate test Hot plate latency was measured to a further evaluation of ABA aptitude for modulating nociception induced by heat stimuli. Results indicated that i.t. administration of ABA at 10 and 20 µg significantly decreased nociceptive threshold in comparison with either the control or vehicle groups. ABA (10 and 20 µg) significantly caused an analgesic effect at 30 min after the beginning of the test (p<0.001). Moreover, data showed that 10 and 20 µg ABA-related analgesia persisted up to 45 min (Figure 2A ). However, pretreatment i.t. administration of H.89 (100 nM) significantly inhibited ABA (10 µg) increased the mean of latency time in the hot plate test ( Figure 2B ). These findings showed that ABA analgesic effects might be mediated with PKA activities.
Western blot
In the present study, the western blot analysis was performed to assess the effect of i.t. administration of either ABA (10 µg) or H.89 (100 nM), plus ABA (10 µg) on p-ERK expression in the lumbar spinal, following acute thermal stimulation. Results showed that i.t. administration of ABA at 20 µg could significantly increase the spinal level of p-ERK. However, the down regulatory effect ABA on p-ERK expression was inhibited by H.89 (100 nM) as PKA inhibitor (Figure 3) . It suggests that ABA inhibitory effect on p-ERK expression could be achieved by the modulation of PKA signaling. possible antinociceptive effects of phytohormone ABA and its possible molecular mechanism in the spinal cord level using tail flick and hot plate tests. Data revealed that intrathecal microinjection of ABA elicited antinociceptive effects, which was blocked by the PKA inhibitor. In addition, the results showed that microinjection of analgesic doses of ABA could decrease the lumbar spinal levels of p-ERK. To support that, it has been previously reported that the central administration of ABA was able to increase thermal nociception threshold in both the tail flick and the hot plate, whereas it could decrease formalin-induced inflammation in rats 13 . Our data showed that ABA analgesic effect was accompanying p-ERK's down expression in the spinal cord. Numerous studies confirmed that there is a relation between p-ERK and neural stimulation in spinal neurons and glia 19, 20 . The reduction of nociception was proved to be closely associated with the expressions of several signal transduction molecules, such as p-ERK in the spinal cords of mice 21 . In addition, Park et al. reported that the antinociceptive effect of oxyntomodulin appears to be partly mediated by the reduction of p-ERK level in the spinal cord 22 . Besides that, the inhibition of neuronal p-ERK expression was able to suppress acute abdominal pain 23 . Moreover, Cruz et al. reported that pharmacological blockade of ERK phosphorylation in the spinal cord could attenuate nociceptive behaviors in monoarthritic rats 24 . Thus, pharmacological research using ERK blockers would be useful to define the mechanism underlying ABA analgesic effects.
DISCUSSION
ABA signaling pathway in animals' species, such as hydroid and sponges, stimulate target cell increasing the cAMP concentration and PKA activity 25, 26 . Moreover, PKA contributes in the signaling pathway of ABA in murine and human pancreatic β-cells so that the application of PKA inhibitor can suppress the ABA-stimulated insulin secretion in pancreatic β-cells 12 .
PKA plays an important role in amplifying the production of some neuropeptides and regulates their gene expression 27 . It has been indicated that the gene expression and secretion of MET-enkephaline, a pain modulatory neuropeptide, is regulated by PKA 28 . MET-enkephaline binds to respective receptors regions modulating nociception, opioid receptors, which are positioned on nerve fibers on the injured area and can strongly repress excitatory neurotransmitters release and modulate calcium channel activity in nerve ending 29, 30 . Additionally, cAMP/PKA activation induces the release of α-MSH in the central nervous system, as an anti-inflammatory neuropeptide, during the inflammatory promoting process 31 . α-MSH activity leads to a decrease in producing and releasing chemokine and cytokines, which are involved in inflammation 31 .
PKA is also known as a key target, which modulates synaptic transmissions by inhibitory neurotransmitters.
In vivo studies indicated that PKA has functional roles in regulating glycine currents through the phosphorylating of glycine receptors subunits. Increased PKA activityinduced phosphorylation of glycine receptors subunits in trigeminal as well as spinal neurons after exposure to the damaging stimulations has a fundamental role in the synaptic inhibition control 32, 33 . Study results showed that ABA activity in animal tissues lead to the release of glycine 34 . It has been indicated that PKA promotes the expression of GABAA-R subunits in CNS and GABAA-R signaling can regulate other neurotransmitters release from nerve ending, which reduces excitable output from lower spinal cord layer 35, 36 . Therefore, in this study, PKA dependent-potentiation of glycine or GABA signaling, at least partially, might be involved in ABA analgesic activity.
In the current study, rats treated with ABA (10 µg/rat), 30 min after the application, showed a higher tail flick latency in comparison with ABA (20 µg/rat). However, there were no statistically significant differences in reaction to heat stimulus between groups in the rest of the time course experiment. It is already indicated ABA physiological effects are achieved in a concentration-dependent manner 11, 37 . Spatially, our last studies indicated that the central microinjection of ABA (10 µg/rat) is enough to improve spatial learning and memory performances and to suppress thermal and inflammatory nociception in adult male rats 11, 13 . In the present study, to find the most effective dose of ABA for preventing nociception, we also administrated ABA 20 µg/rat, which surprisingly had no different effects from that of ABA at the dose 10 µg/rat.
Moreover, data showed that ABA (10 µg/rat) analgesic effect was more effectual in the tail flick than in the hot plate test. In experimental settings, both apparatus are widely used to assess thermal nociception; however, there are some structural differences between tests, which could affect the experiments outcome 38,39 . Most importantly, the different heat radiation levels have been used in each test. In addition, the tail flick test evaluates thermal nociception reflex by applying heat radiant to tail, whereas the hot-plate test assesses pain behavior as a result of footpad contact with a heated surface 39 .
In conclusion, our results showed that rat's intrathecal application of ABA as phytohormone could induce significant analgesic effects and decrease p-ERK expression. The ABA effects were inhibited following pharmacological inhibition of PKA activity.
